1. | We note your response to comment 1 of our letter dated July 20, 2009. Please be advised that you may redact information from your filing pursuant to an application for confidential treatment filed under Exchange Act Rule 24b-2 and that Rule 24b-2 sets forth the exclusive means for obtaining confidential treatment of information contained in a document filed that would be exempt from disclosure under the Freedom of Information Act. Failure to comply with either the substantive or procedural aspects of the Commission confidential treatment process may result in a denial of an application. | |
Response: | ||
We will file a complete copy of the credit agreement that includes the omitted schedules and exhibits with our upcoming quarterly report on Form 10-Q for the period ended June 30, 2009. |
If you have any questions or comments regarding this memorandum, please contact Roy Rumbough, our Interim Chief Financial Officer, at 972-497-5520. |